David Feldman
Oprichter bij GlyGenix Therapeutics, Inc.
Actieve functies van David Feldman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
GlyGenix Therapeutics, Inc.
 GlyGenix Therapeutics, Inc. BiotechnologyHealth Technology GlyGenix Therapeutics, Inc. focuses on treating and curing Glycogen storage diseases. The firm’s services include development of nucleic acid molecules that compensate or correct the genetic defects that cause Glycogen storage disease type 1a. The company was founded by David Feldman and Peter Kaufman in 2006 and is headquartered in Woodbridge, CT. | Directeur/Bestuurslid | 01-01-2006 | - |
| Operationeel Directeur | 01-01-2006 | - | |
| Oprichter | 01-01-2006 | - | |
The UCAN Co.
 The UCAN Co. Food RetailRetail Trade The UCAN Co. manufactures energy drink for sports nutrition. The company is headquartered in Woodbridge, CT. | Directeur/Bestuurslid | - | - |
Loopbaan van David Feldman
Statistieken
Internationaal
| Verenigde Staten | 3 |
Operationeel
| Director/Board Member | 2 |
| Chief Operating Officer | 1 |
| Founder | 1 |
Sectoraal
| Retail Trade | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
The UCAN Co.
The UCAN Co. Food RetailRetail Trade The UCAN Co. manufactures energy drink for sports nutrition. The company is headquartered in Woodbridge, CT. | Retail Trade |
GlyGenix Therapeutics, Inc.
GlyGenix Therapeutics, Inc. BiotechnologyHealth Technology GlyGenix Therapeutics, Inc. focuses on treating and curing Glycogen storage diseases. The firm’s services include development of nucleic acid molecules that compensate or correct the genetic defects that cause Glycogen storage disease type 1a. The company was founded by David Feldman and Peter Kaufman in 2006 and is headquartered in Woodbridge, CT. | Health Technology |
- Beurs
- Insiders
- David Feldman
- Ervaring
